![Seth V. Hetherington](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Seth V. Hetherington
Directeur/Membre du Conseil chez
Apie Therapeutics, Inc.
Profil
Seth V.
Hetherington is currently a Director at Apie Therapeutics, Inc. He previously held positions as Chief Medical Officer & VP-Clinical Development at Inhibitex LLC, SVP-Clinical & Regulatory Affairs at Neusentis, Inc., Chief Medical Officer at Genocea Biosciences, Inc., and Senior VP-Clinical & Regulatory Affairs at Icagen, Inc. He also worked as Head-Clinical Program at GlaxoSmithKline, Inc. and Glaxo Wellcome, Inc. Additionally, he worked as a Principal at The University of North Carolina at Asheville.
Hetherington received his undergraduate degree from Yale University and his doctorate from The University of North Carolina at Asheville.
Postes actifs de Seth V. Hetherington
| Sociétés | Poste | Début |
|---|---|---|
Apie Therapeutics, Inc.
 Apie Therapeutics, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Directeur/Membre du Conseil | - |
Anciens postes connus de Seth V. Hetherington
| Sociétés | Poste | Fin |
|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 30/01/2018 |
Neusentis, Inc.
 Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel orally administered small molecule drugs | Directeur Technique/Scientifique/R&D | 31/12/2010 |
Icagen, Inc.
 Icagen, Inc. Medical SpecialtiesHealth Technology Develops pharmaceutical and drug discovery instruments | Directeur Technique/Scientifique/R&D | 01/12/2010 |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Develops drugs | Directeur Technique/Scientifique/R&D | 01/06/2006 |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Corporate Officer/Principal | 01/06/2002 |
Formation de Seth V. Hetherington
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
Neusentis, Inc.
Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel orally administered small molecule drugs | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Develops pharmaceutical and drug discovery instruments | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Glaxo Wellcome, Inc.
 Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
The University of North Carolina at Asheville
 The University of North Carolina at Asheville Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apie Therapeutics, Inc.
Apie Therapeutics, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
